Default company panoramic image

Mirexus Inc.

The world’s only safe, non-toxic, edible, organic, mono-disperse nanomaterial (patent-pending) … that you can grow in the field next door!

  • Stage Prototype Ready
  • Industry Nanotechnology
  • Location Guelph, ON, Canada
  • Currency CAD
  • Founded March 2008
  • Employees 4
  • Website

Company Summary

Mirexus is built on a patent-pending new nanomaterial made from corn. It is the world’s only safe, non-toxic, edible, organic, mono-disperse nanomaterial. It is a platform technology that has applications in multiple markets; most notably Personal Care (cosmetics), Nutraceuticals, and Pharmaceuticals. The addressable market is huge. We displace "expensive & toxic" with "affordable & safe”.


  • 68b8f115 3950 41ab 91dc bffcc3bdbc49
    President & CEO

    Phil has a strong background in technology commercialization and executive management. Most recently, Phil was President and CEO of a renewable energy company. Prior experience includes being President of an international robotics and automation company, President of a fuel cell and rechargeable battery company, and VP roles in R&D and Engineering with a global water treatment company and a multi-national forest products company. Phil has also se

  • Default avatar
    Erzsebet , Ph.D. Papp-Szabo
    Founder & Senior Research Scientist

    Erzsebet has a PhD in Biochemistry from the University School of Medicine, Debrecen, Hungary. She has extensive experience in developing and successfully carrying out research projects in the areas of biochemistry, cell biology, microbiology and polysaccharide chemistry. Erzsebet played a fundamental role in establishing Mirexus Biotechnologies’ platform technology and serves as the Lead Product Development Scientist within the company.
    She h

  • 60dfcd0a 3311 4cd4 87da 9332ea7a668f
    Founder & Senior Research Scientist

    Anton has a PhD in Microbiology and has a strong background in biotechnology. He is an expert in a broad range of experimental techniques in microbiology, biochemistry and materials science. Currently Anton serves as Senior Scientist at Mirexus where he is responsible for product and process development. Previously, he was as a Research Associate at the Department of Physics at the University of Guelph. Anton previously worked as a Research Scie

  • Abe1b088 6cf8 43ab a920 351833469ac4
    Founder & Board Chairman

    John is a Professor of Physics, Senior Canada Research Chair in Soft Matter and Biological Physics, and Director of the Nanoscience program at the University of Guelph. John’s research focuses on the properties and practical applications of novel biological polymers and nanomaterials. For his research accomplishments, he received the Premier’s Research Excellence Award in 2000, and was elected as a Fellow of the American Physical Society in 2007.

  • Greg has extensive operational and transactional experience in the financial services industry. He was an Equity Analyst at Neuberger Berman before joining American Strategic Insurance (ASI) where he served as Chief Financial Officer. ASI’s revenue grew from $38 million to $506 million during Greg’s tenure. Greg has structured and/or executed $168 million of transactions. He has a BSBA and an MBA.


  • Default avatar
    David Pamenter - Partner - Gowlings
    Eb0c83f9 019d 438a 8377 c32265104ed3
    Default avatar
    Lorelei Graham
    Partner - Norton Rose Fulbright